Sabby Management, LLC Nrx Pharmaceuticals, Inc. Transaction History

Sabby Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.23 - $0.5 $86,188 - $187,365	-374,731 Reduced 53.55%	325,000 $84,000
Q2 2023 Aug 14, 2023	BUY	$0.46 - $0.89 $321,876 - $622,760	699,731 New	699,731 $335,000
Q2 2022 Aug 15, 2022	SELL	$0.51 - $2.42 $297,061 - $1.41 Million	-582,473 Reduced 74.44%	200,000 $120,000
Q1 2022 May 16, 2022	BUY	$2.45 - $5.04 $1.92 Million - $3.94 Million	782,473 New	782,473 $1.92 Million

17.4K

Ticker NRXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,641,296
Market Cap $81.2M
Description
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.